SFX by Ex Libris Inc.

Title:	Cellular and molecular mechanism of low-turnover osteopenia in the klotho -deficient mouse
Source:	Cellular and Molecular Life Sciences [1420-682X] Kawaguchi, H yr:2000

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Hu, Ming C. "Klotho deficiency causes vascular calcification in chronic kidney disease." Journal of the American Society of Nephrology 22.1 (2011): 124-136.
description	2.	Moe, Orson W. "Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective." Kidney international 78.12 (2010): 1240-1251.
description	3.	Fonseca, I. "First-year renal function predicts long-term renal allograft loss." Transplantation proceedings (2011): 106-112.
description	4.	de Baaij, Jeroen H F H. "Regulation of magnesium balance: lessons learned from human genetic disease." Clinical Kidney Journal 5.Suppl1 (2012).
description	5.	Hsiao, L. "Vascular klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23." Circulation 125.18 (2012): 2243-2255.
description	6.	Han, Dong H. "Effect of sirolimus on calcineurin inhibitor-induced nephrotoxicity using renal expression of KLOTHO, an antiaging gene." Transplantation 90.2 (2010): 135-141.
description	7.	Linkermann, A. "Renal tubular Fas ligand mediates fratricide in cisplatin-induced acute kidney failure." Kidney international 79.2 (2011): 169-178.
description	8.	Silver, J. "FGF23 and the parathyroid glands." Pediatric Nephrology 25.11 (2010): 2241-2245.
description	9.	Park, So-Youn Y. "The relationship between circulating fibroblast growth factor 23 and bone metabolism factors in Korean hemodialysis patients." Clinical and Experimental Nephrology 14.3 (2010): 239-243.
description	10.	E. Ichimoto, K. Jo, Y. Kobayashi, T. Inoue, Y. Nakamura, N. Kuroda, A. Miyazaki and I. Komuro, I. "Prognostic significance of cystatin C in patients with ST-elevation myocardial infarction." Circulation journal : official journal of the Japanese Circulation Society 73.9 (2009): 1669-73.
description	11.	Tepel, M. "Soluble α-Klotho and Its Relation to Kidney Function and Fibroblast Growth Factor-23." The Journal of clinical endocrinology and metabolism 99.5 (2014).
description	12.	Leopold, Jane A. "Vascular calcification: Mechanisms of vascular smooth muscle cell calcification." Trends in cardiovascular medicine 25.4 (2014): 267-274.
description	13.	Volpe, Stella L. "Magnesium in disease prevention and overall health." Advances in nutrition 4.3 (2013): 378-383.
description	14.	Mooney, T. "Cardiovascular disease." Nursing standard 26.39 (2012): 59-59.
description	15.	Kendrick, J. "FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis." Journal of the American Society of Nephrology 22.10 (2011): 1913-1922.
description	16.	Berciano, J. "Reduced penetrance in hereditary motor neuropathy caused by TRPV4 Arg269Cys mutation." Journal of neurology 258.8 (2011): 1413-1421.
description	17.	Weintraub, Howard S. "Potential benefits of aliskiren beyond blood pressure reduction." Cardiology in review 19.2 (2011): 90-94.
description	18.	Hindorff, Teri A. "Potential etiologic and functional implications of genome-wide association loci for human diseases and traits." Proceedings of the National Academy of Sciences of the United States of America 106.23 (2009): 9362-9367.
description	19.	Laroche, M. "Intraosseous circulation from physiology to disease." Joint, bone, spine 69.3 (2002): 262-9.
description	20.	Varni, James W W. "Health-related quality of life measurement in pediatric clinical practice: an appraisal and precept for future research and application." Health and quality of life outcomes 3.2005 (2005): 34-34.